ArticleSexually transmitted diseases2026
Evaluation of the Electronic Health Record as a Tool for Maternal and Congenital Syphilis Surveillance.
Article in Sexually transmitted diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Gaps in Syphilis Screening Among Pregnant Women in North Carolina.Sexually transmitted diseases · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundEarly entry into prenatal care and timely syphilis diagnosis and treatment of pregnant women can prevent congenital syphilis (CS). We assessed syphilis testing and treatment for pregnant women and their infants using electronic health records (EHRs).
methodsWe extracted syphilis testing results from pregnancy episodes documented in EHRs for women seeking care at the Medical University of South Carolina health system during 2021-2022. Chart reviews confirmed syphilis diagnosis, stage, and treatment. We calculated percentages of pregnant women who were (1) screened for syphilis, (2) received abnormal (i.e., reactive) test results, (3) newly diagnosed with syphilis, and (4) adequately treated for syphilis before delivery. We assessed testing and treatment outcomes of infants exposed to maternal syphilis.
resultsAmong 12,959 pregnant women, 75% (n = 9708) had ≥1 syphilis test during pregnancy; 106 (1.1%) had ≥1 abnormal test. From chart reviews, 54 women (51%) with abnormal test results were newly diagnosed with syphilis. The remaining abnormal test results were false positives (n = 15) or previous diagnoses (n = 37). Forty-four (81%) new diagnoses were treated during pregnancy; 30 (56%) were treated >30 days before delivery. Fifty-six infants born to women with an abnormal syphilis test result were evaluated for CS, of whom 24 (43%) had abnormal test results and 18 (75%) were treated for CS.
conclusionsAlthough EHRs could reliably assess syphilis testing during pregnancy, chart review and consultation with public health authorities were necessary to confirm adequate treatment and CS follow-up. Triangulating EHRs with other data sources could enhance the understanding of syphilis during pregnancy and inform CS prevention efforts.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.